Cytotoxicity Testing Services for Medical Devices & Materials
Cytotoxicity tests are those in which the biocompatibility of a material through in vitro (in glass) tests is checked. Biocompatibility tests, like tests for cytotoxicity, are necessary to check for the compatibility of any material with any medical device or/and any living tissue.
TRUSTED BY
Precision Testing Solutions for Accurate, Reliable, and Standards-Compliant Results
- Overview
- Scope, Applications, and Benefits
- Test Process
- Specifications
- Instrumentation
- Results and Deliverables
Cytotoxicity Testing-Overview
Cytotoxicity testing evaluates whether a medical device material, extract, or component causes cell death, inhibits cell growth, or produces morphological changes in mammalian cell cultures under controlled laboratory conditions. It is the foundational in vitro biocompatibility test in the ISO 10993 framework — conducted per ISO 10993-5 — and is typically the first biological safety test performed on any device material because of its broad sensitivity, short turnaround, and ability to detect cytotoxic leachables before committing to longer and more resource-intensive in vivo studies.
For medical device manufacturers, cytotoxicity testing is not optional. FDA’s biocompatibility guidance and ISO 10993-1 both require cytotoxicity evaluation for all devices with direct or indirect patient contact regardless of contact duration or device classification. A passing cytotoxicity result is a prerequisite for 510(k) submissions, PMA applications, CE marking under EU MDR, and device registration with Health Canada, TGA, and PMDA. Failing to include compliant ISO 10993-5 data in a regulatory submission is a common cause of FDA deficiency letters and EU notified body queries.
Scope, Applications, and Benefits
Scope
ISO 10993-5 covers three cytotoxicity test methods, each suited to different device material forms and contact scenarios. All three methods use established mammalian cell lines — typically L-929 mouse fibroblasts — and evaluate cell response after exposure to the test article or its extract over a defined incubation period. Sample preparation follows ISO 10993-12, which specifies extraction vehicles, temperature, duration, and surface area-to-volume ratios appropriate to the device’s clinical use conditions.
ISO 10993-5 cytotoxicity methods include:
- Extract test (elution method) — device is extracted in a physiological vehicle; the extract is applied to the cell monolayer. Most widely used method; applicable to all device types regardless of geometry or surface area
- Direct contact test — device material is placed directly on the cell monolayer. Sensitive method suited to flat materials, films, and membranes; detects surface-mediated cytotoxicity not captured in extracts
- Indirect contact test (agar diffusion) — device is placed on an agar overlay above the cell monolayer; diffusible leachables migrate through the agar to reach the cells. Used for devices where direct contact with cells is impractical
Applications
- EU MDR CE marking technical documentation requiring ISO 10993-5 cytotoxicity data as part of the biological evaluation report.
- New material qualification for medical-grade polymers, silicones, adhesives, coatings, and metallic alloys before device design freeze.
- Material change assessment when supplier, formulation, or manufacturing process changes require biocompatibility re-evaluation per ISO 10993-1.
- Combination product biocompatibility screening for drug-device combinations where device material contact with biological tissues requires cytotoxicity confirmation.
- Finished device lot release testing where cytotoxicity is included as a quality control endpoint for implantable or critical-contact device production.
- Early-stage development screening to identify cytotoxic formulation components before investing in full ISO 10993 test programs.
Benefits
- Short turnaround — typically 2–3 weeks — makes it the fastest regulatory biocompatibility data point to generate.
- Three method options ensure the most appropriate approach is selected for the device material form and contact scenario.
- In vitro methodology eliminates animal use for this endpoint per ISO 10993-1 requirements.
- GLP-compliant reports from accredited laboratories accepted across all major regulatory jurisdictions simultaneously.
Cytotoxicity Testing-Test Process
Sample Preparation
Prepare test material or extract according to specified extraction conditions and sterilize if required.
1Cell Culture Preparation
Culture mammalian cells under controlled conditions until suitable confluency is reached.
2Exposure to Test Sample
Expose cells to the material or extract for a defined incubation period under controlled temperature and CO₂ conditions.
3Evaluation & Interpretation
Evaluate cell viability and morphology using appropriate assays to determine cytotoxic response.
4Cytotoxicity Testing-Technical Specifications
| Parameter | Details |
|---|---|
| Test Type | In vitro cell-based biological evaluation |
| Cell Lines | Commonly L929 mouse fibroblast or other validated mammalian cell lines |
| Test Methods | Extract method, direct contact method, or agar diffusion method |
| Extraction Conditions | Defined surface area-to-volume ratio, temperature , and duration. |
| Incubation Conditions | 37 °C, 5% CO₂, controlled humidity |
| Exposure Duration | Typically 24–72 hours |
| Evaluation Parameters | Cell viability, Cell morphology changes, Growth inhibition. |
| Assessment Methods | MTT assay, XTT assay, Neutral Red uptake, or visual grading |
| Controls | Negative (non-toxic) and positive (cytotoxic). |
Instrumentation Used for Testing
- CO₂ Incubator
- Biological Safety Cabinet (Laminar Air Flow)
- Inverted Microscope
- Microplate Reader (ELISA Reader)
- Centrifuge
- Analytical Balance
- Water Bath
- Autoclave
- Pipettes and Micropipettes
Results and Deliverables
Cell Viability Percentage (%)
Cytotoxicity Grade / Reactivity Score
Microscopic Observations (Cell Morphology)
Growth Inhibition Data
Test Method and Extraction Details
Control Performance Results
Interpretation of Cytotoxic Response
Complete Test Report
Frequently Asked Questions
Cytotoxicity testing determines the toxic effects of a material or medical device on cultured mammalian cells. This is a method used to determine the biological safety of a material or a medical device for clinical or human contact use.
It ensures that materials do not release harmful substances that can damage cells, supporting regulatory compliance, patient safety, and product approval in medical and healthcare industries.
Common methods include extract testing, direct contact testing, and agar diffusion techniques, where cell viability, morphology, and growth inhibition are assessed using quantitative and qualitative evaluation criteria.
Results typically include percentage cell viability, cytotoxic response grading, microscopic observations of cell morphology, and a conclusion stating whether the material meets acceptance criteria under specified test conditions.
Cytotoxicity testing for medical devices is commonly performed according to ISO 10993-5. In the United States, the FDA recognizes this standard as the primary method for proving your material is safe for human contact.
Why Choose Infinita Lab for Advanced Materials Testing and Characterization?
At the core of this breadth is our network of 2,000+ accredited laboratories across the USA, offering access to over 10,000 testing methods and analytical services. From advanced materials characterization (SEM, TEM, RBS, XPS) to mechanical, chemical, environmental, biological, and standardized ASTM/ISO-compliant testing, we deliver unmatched flexibility, specialization, and scale. You are never limited by geography, facility, or methodology — Infinita Lab connects you to the right expertise and testing solution, every time.
Looking for a Trusted Partner for Accurate and Reliable Testing Services?
Send query us at hello@infinitlab.com or call us at (888) 878-3090 to learn more about our services and how we can support you.
Request a Quote
Submit your material details and receive testing procedures, pricing, and turnaround time within 24 hours.
Quick Turnaround and Hasslefree process
Confidentiality Guarantee
Free, No-obligation Consultation
100% Customer Satisfaction
